New ANSTO board member
29 May, 2014Federal Minister for Industry Ian Macfarlane has announced the appointment of Penny Dobson as a new member of the Australian Nuclear Science and Technology Organisation (ANSTO) board.
Merck Millipore announces incoming CEO and president
15 April, 2014Merck Millipore, the life science division of Merck, has announced the appointment of Dr Udit Batra as its incoming president and CEO. Dr Batra comes to Merck Millipore from the consumer health division of Merck KGaA, where he successfully grew the business in established and emerging markets.
Renowned biological scientist elected to Australian Academy of Science
14 April, 2014A leading British scientist, Professor Sir Philip Cohen FAA FRS FRSE, has been announced as a Corresponding Member of the Australian Academy of Science.
2014 Fellows of the Australian Academy of Science announced
26 March, 2014The Australian Academy of Science has announced the election of 21 leaders in Australian science to its Fellowship.
Samuel Sadoulet named president of Edmund Optics
06 February, 2014Optical components provider Edmund Optics has appointed Samuel Sadoulet as its president. Sadoulet is currently chief operating officer of the company and will retain that title as he leads the company's corporate technology, global engineering and manufacturing operations.
Why do some people not care about science?
03 February, 2014 by Joan Leach and Fabien MedveckySurveys on public attitudes to science regularly tell us that there are swathes of the public that simply seem to not care about science, despite our best effort to engage them. But perhaps the issue is not with the public - the issue is with the question.
Nancy Millis Medal to honour women in science
22 November, 2013The Australian Academy of Science has created a new award - the Nancy Millis Medal - which recognises outstanding research and leadership by early- to mid-career Australian women who have established independent research in the natural sciences.
Director of Australian Synchrotron announced
20 November, 2013The Synchrotron Light Source Australia (SLSA) Board today announced the appointment of Professor Andrew Peele as Director of the Australian Synchrotron. Professor Peele has held the role on an interim basis since the beginning of 2013, overseeing the day-to-day delivery of world-class science at the facility.
New leaders at Trajan
18 October, 2013Trajan has made a number of key appointments to its leadership team.
Continued call for a strategic and stable plan for science
01 October, 2013 by Lauren DavisAustralian scientists and researchers from the Research Alliance have put out a call to policymakers asking for a strategic and stable plan for science and research that will stop the country falling behind the rest of the world.
No science minister for Coalition government?
17 September, 2013 by Lauren DavisPrime Minister-elect Tony Abbott yesterday announced the incoming ministry for the new federal government, to be sworn in this week. It has been observed that several portfolio titles have been simplified, while a minister for science appears to have been omitted altogether.
Custodian of pitch drop experiment dies
05 September, 2013The custodian of the world’s longest running laboratory experiment, Professor John Mainstone, has died at the age of 78 after suffering a stroke. The former Head of the University of Queensland’s (UQ) Department of Physics was the guardian of the world-famous pitch drop experiment.
Senior Cochlear executive Michael Kavanagh named Nanosonics CEO
28 August, 2013 by Dylan Bushell-EmblingNanosonics has tapped senior Cochlear executive Michael Kavanagh to become its next CEO. Kavanagh will take the roles of CEO and president effective 21 October.
Following the herd: the influence of online ratings
15 August, 2013The comments section of online news sites is intended to be a place where everyone can express their own opinion. But according to a study published in the journal Science, many people are heavily influenced by the positive opinions of others in such outlets, while less swayed by the negative ones.
UNSW responds to the ABC’s claim that its research into DZ13 was flawed
13 August, 2013The University of New South Wales responds to claims that the research into the antiskin cancer drug, DZ13, was flawed. Clinical trials have been suspended as a third round of investigations continue.
